Defining valuable information in a shifting industry

Authors

pharmaceuticals, biologics, generics, biosimilars

Andrew F Bourgoin, Thomson Reuters

Andrew Fischer Bourgoin is a Senior Pharmaceutical Research Analyst - Biologcs at Thomson Reuters (TR), the worldâ€™s leading information provider and global media company. In this role, Andrew is responsible for collecting and validating the intelligence contained in the Newport product suite that focuses on developments within the global biologic pharmaceutical landscape.